Avacta Share Discussion Threads

[rajraj b] 21/2/2024 10:39

I'm still here Amaan. Waiting patiently.

[ohwhatfun] 21/2/2024 10:13

Log

Some points.

Avacta is far too early in process (trials) to attract backers, the numbers involved are too low. Hence that is a very slim chance event.

Even then it appears increased doses failed to meet the same standard as the original Dox, safety up efficacy not. Not an efficacy trial they say, safety, but it's sample of efficacy regardless of the phase 1 label.
There are a host of phase 1 safety trials where efficacy has been better than the standard of care.

April, Bond.

I'm trying to get my head around the bond, your April comment, floor reset 18 months, the lower limit appears to be 95p

But then it states "save in limited circumstances there is a reset price floor of 95p"

No explanation of that, but I guess the limited circumstances relate to share price performance (EG 95p breached), so that floor of 95p is likely to drop, potentially materially.


The bond can also convert partially at any time at the bond holders discretion. As is typical, the full details about the bond are not in there.


Always fun to see negativity thrown at warning posts about how vicious the city can be when it comes to fund raise time. Pure tunnel vision by the city vultures, crash it as much as possible to maximise returns, they don't give a damn about the company.

Private investors seem to fight against what is blatantly obvious, a hope that some Good Samaritan will appear with the cash, ignoring the likely discounted fund raise reality.


Fingers crossed there are not too many private investors geared beyond their means, there are always some, and no doubt sleepless nights already in play.

I do not wish those crash events on them, it's vile, they get wiped out, the city does not care, it's just another successful day at the office to them,

[atmysignal] 21/2/2024 10:02

Looks like 80p coming

[loglorry1] 21/2/2024 09:27

I just don't think the tech is exciting enough to attract a partner. There has been no independent validation of the tech in any papers I can find. Obviously the PI holders here shout from the rooftops about the efficacy but they would wouldn't they. No credible player has taken an equity position. Furthermore, the companies track record for bringing tech and test tech to market is dreadful.

Smith is incredibly well paid to bang the drum for AVA6K and has hired a lot of other key opinion leaders to do the same but if it had the potential he says it has you'd see other industry participants also talking about it.

Over to @tickboo to find some links online which are independent. Tip: posters and conference papers don't count.

[amanitaangelicus] 21/2/2024 09:08

Need a partner deal ...only way to stop a share price collapse. Blindingly obvious to the sane. What peeps are sniffing is beyond me. Fingers, toes crossed for our LTHs here ...just Chesh left I suspect. The test just traders pretending to be LTHs. Even Raj has run away.

[ohwhatfun] 20/2/2024 22:21

Nothing wrong in warning about city antics, it’s what they do, a sniff of weakness and they are in for the kill.

That has been typical on AIM but this last year has been devastating for small public companies on the AIM, diluted to oblivion.



I see Amte power fell off the AIM cliff today.

Bens creek, Tirupati and a host of others were AIM darlings, pumped and retail masses drawn in.

Many have gone £100m plus to under £10m and low single figures.

It’s not posters or negative views that do that, it’s market reality.

Retail have kept Avacta flying high defying gravity, when the rest have fallen. The highs created by Covid and LFT hype.

Now the hope is a prodrug approach, it may or may not get to market.

Avacta need relevant funds backing it not discount raise flippers.

Hopefully Avacta have something up their sleeve for private investors, to bypass the wolf pack lying in wait.

I can only guess how much they need, but in the current share price trend they need to get on with it.

It certainly looks like a worked drop knowing the collection tin will have to be passed around soon.

[amanitaangelicus] 20/2/2024 20:43

Probs got share options galore ...channy of being millionaires Del Vertiz. 12 upticks - winner!

[loglorry1] 20/2/2024 17:20

Chart looks pretty horrid. I guess the raise can't be too far away.

[amanitaangelicus] 20/2/2024 09:00

Waiting ... financing needs sorting. The longer this goes on, the worse it will be. Dont like Radio Silence. Hope you strike lucky. Convis - hate em. Only weak companies end up with em, companies who.ve blown previously normal placings. Sequoia? 120p prior placing. With hindsight, Smith played us like a violin. Wary as, now. Not many peeps screaming buy now. Many just trapped praying for good news. We.ve all been there, many times. Gambling ...that.s what this is ...gambling. GL.

[fieldhouse] 20/2/2024 08:46

Which way are you going to jump Aman. ?

[amanitaangelicus] 20/2/2024 08:29

Another juicy volume day inbound. Price action with volume is always jolly important. Watch carefully...

[amanitaangelicus] 19/2/2024 21:11

2 almost identical volume days and buys/ sells figs ...approx double previous 2 days. This alone is interesting. Tomorrow should be fun. Perking up. GLA tomorrow.

[peterm10] 19/2/2024 17:35

https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.newscientist.com/podcasts/transforming-clinical-trials-episode-1/&ved=2ahUKEwiv9Pq-97eEAxXYUUEAHVW3DNoQFnoECCoQAQ&usg=AOvVaw0MtXkFIPIjssKYBushBPlfInteresting New Scientist sponsored podcast ..believe it's free and I'm not breaking rules.

[blackvulture] 19/2/2024 16:32

Looks like the bottoms in now should start heading back up tomorrow

[fieldhouse] 19/2/2024 16:19

Iofina down 2% today.
Oh dear!!, more than avacta !

[fieldhouse] 19/2/2024 16:13

Thank you much ohwhatfun for your fantastic analysis of Avacta.
For someone who is clearly not invested here you have put a lot of time and effort into knocking the company and its strategy.
Have you an evangelical desire to save wayward investors from the sins of listening to learned cancer specialists .

Your nickname gives the game away.
Go away and play with your iodine

Clearly a paid deramper

PS
The P1 safety trial has been an outstanding success.
It was not designed for efficacy with terminally ill patients that had received almost their limit of dox.
To have signs when not expected where a real plus.

[ohwhatfun] 19/2/2024 15:31

Tick

You are either completely blinkered or you’re deliberately ignoring market reality.

Avacta is on a bonkers £260m market cap courtesy of an excited retail army.

Avacta are trying to improve the combustion engine when the bio market is chasing the new way.

It was bad enough before immunotherapy to get any interest for early phase trials which is where Avacta are.

That means there is a very slim chance indeed that any big names are interested in a deal right now.

Safety is up response rates were worse than standard Dox. Tougher blah blah blah, as some say, but other too treatments have only the tough cancers to beat, with early signs of better than standard of care.

So Avacta will likely need to go to the market, the market will cringe at the market cap.
If Avacta needs money from the city the share price will have to come down.

Any sign of weak interest, then the market will kill the share price pre discount.

So don’t be surprised to see a continued dive, that’s what they do.

[loglorry1] 19/2/2024 11:36

Faron Pharma FARN showing what happens to equity investors when you run out of money and can't afford to fund a trial!

[loglorry1] 19/2/2024 11:34

OK PWhite if you say so. I don't own a Lamborghini because I don't want one but I can afford to buy several if I sold one portfolio position. I don't think I've ever owned AIM junk other than for a quick trade. Anyway I don't want to talk to you anymore as you are offensive.

[pwhite73] 19/2/2024 10:22

loglorry1 - "With AVCT you are 100% buying an intangible asset which is the claims that the management are making and you have no way to know if they are true or not."

Whether intangible or tangible assets as private investors we have no way of knowing if the management are telling the truth or not.

An AIM oil company reports back the licenced area has proven resources of a billion barrels of oil. Are they telling the truth or lying to get away the next placing.

On all stocks you have to make your own judgement based on what others post, RNS statements and your own experience.